Trial Profile
Open-label, randomized study comparing the patient reported severity of GI [gastrointestinal] side effects of MMF [mycophenolate mofetil] versus EC-MPS [enteric coated-mycophenolate sodium] in maintenance heart transplant patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2019
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Mycophenolate mofetil
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 10 Jul 2007 New trial record.